PL2958893T3 - Asymetryczna synteza podstawionego pirolidyno-2-karboksyamidu - Google Patents

Asymetryczna synteza podstawionego pirolidyno-2-karboksyamidu

Info

Publication number
PL2958893T3
PL2958893T3 PL14706519T PL14706519T PL2958893T3 PL 2958893 T3 PL2958893 T3 PL 2958893T3 PL 14706519 T PL14706519 T PL 14706519T PL 14706519 T PL14706519 T PL 14706519T PL 2958893 T3 PL2958893 T3 PL 2958893T3
Authority
PL
Poland
Prior art keywords
carboxamide
asymmetric synthesis
substituted pyrrolidine
pyrrolidine
substituted
Prior art date
Application number
PL14706519T
Other languages
English (en)
Inventor
Daniel Fishlock
Chen Gu
Lianhe Shu
Pankaj Devdatta Rege
Keshab Sarma
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL2958893T3 publication Critical patent/PL2958893T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Catalysts (AREA)
PL14706519T 2013-02-21 2014-02-18 Asymetryczna synteza podstawionego pirolidyno-2-karboksyamidu PL2958893T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361767395P 2013-02-21 2013-02-21
US201361909520P 2013-11-27 2013-11-27

Publications (1)

Publication Number Publication Date
PL2958893T3 true PL2958893T3 (pl) 2017-09-29

Family

ID=50179579

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14706519T PL2958893T3 (pl) 2013-02-21 2014-02-18 Asymetryczna synteza podstawionego pirolidyno-2-karboksyamidu

Country Status (18)

Country Link
US (1) US9828340B2 (pl)
EP (1) EP2958893B1 (pl)
JP (1) JP6148351B2 (pl)
KR (1) KR101726116B1 (pl)
CN (2) CN107686459A (pl)
AU (1) AU2014220865B2 (pl)
BR (1) BR112015015880B1 (pl)
CA (1) CA2894826C (pl)
DK (1) DK2958893T3 (pl)
ES (1) ES2630392T3 (pl)
HU (1) HUE033534T2 (pl)
IL (1) IL239888B (pl)
MX (1) MX365948B (pl)
PL (1) PL2958893T3 (pl)
RU (1) RU2015133939A (pl)
SG (1) SG11201505150TA (pl)
SI (1) SI2958893T1 (pl)
WO (1) WO2014128094A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10227298B2 (en) 2014-04-15 2019-03-12 Hoffmann-La Roche Inc. Solid forms of a pharmaceutically active compound
GB201919219D0 (en) 2019-12-23 2020-02-05 Otsuka Pharma Co Ltd Cancer biomarkers
KR20230058124A (ko) 2020-08-27 2023-05-02 오츠카 세이야쿠 가부시키가이샤 Mdm2 길항제를 사용하는 암 치료를 위한 생체표지자
GB202103080D0 (en) 2021-03-04 2021-04-21 Otsuka Pharma Co Ltd Cancer biomarkers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8354444B2 (en) * 2008-09-18 2013-01-15 Hoffmann-La Roche Inc. Substituted pyrrolidine-2-carboxamides
US20120010235A1 (en) * 2010-07-12 2012-01-12 Xin-Jie Chu N-substituted pyrrolidines
US20120046306A1 (en) 2010-08-18 2012-02-23 David Joseph Bartkovitz Substituted Heteroaryl Spiropyrrolidine MDM2 Antagonists
US20120065210A1 (en) * 2010-09-15 2012-03-15 Xin-Jie Chu Substituted hexahydropyrrolo[1,2-c]imidazolones

Also Published As

Publication number Publication date
BR112015015880A2 (pt) 2017-07-11
CA2894826A1 (en) 2014-08-28
CA2894826C (en) 2021-03-23
DK2958893T3 (en) 2017-07-10
US20160002158A1 (en) 2016-01-07
CN107686459A (zh) 2018-02-13
JP2016509037A (ja) 2016-03-24
KR20150109439A (ko) 2015-10-01
CN105026370A (zh) 2015-11-04
MX2015010561A (es) 2015-11-16
AU2014220865A8 (en) 2015-08-20
KR101726116B1 (ko) 2017-04-11
CN105026370B (zh) 2017-11-10
BR112015015880B1 (pt) 2022-07-19
WO2014128094A1 (en) 2014-08-28
HUE033534T2 (en) 2017-12-28
ES2630392T3 (es) 2017-08-21
RU2015133939A (ru) 2017-03-27
IL239888B (en) 2018-11-29
JP6148351B2 (ja) 2017-06-14
US9828340B2 (en) 2017-11-28
IL239888A0 (en) 2015-08-31
AU2014220865B2 (en) 2017-03-30
MX365948B (es) 2019-06-19
EP2958893A1 (en) 2015-12-30
SG11201505150TA (en) 2015-09-29
EP2958893B1 (en) 2017-05-03
HK1211294A1 (en) 2016-05-20
SI2958893T1 (sl) 2017-08-31
AU2014220865A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
GB201421334D0 (en) Synthesis of aeizeolite
GB201311910D0 (en) Novel Compounds
GB201311888D0 (en) Novel compounds
GB201317363D0 (en) Novel compounds
GB201318222D0 (en) Novel compounds
GB201314926D0 (en) Novel Compounds
GB201416171D0 (en) Fungical mixture
IL239888B (en) Asymmetric synthesis of modified pyrrolidine-2-carboxamide
PL2978750T3 (pl) Synteza Dabigatranu
GB201322512D0 (en) Novel compounds
ZA201507100B (en) Synthesis of bace1 inhibitors
PT2799426T (pt) Novo processo para a síntese de aminaftona
GB201320021D0 (en) Novel Compounds
AU353260S (en) Top portion of a speaker for a light bar
EP2852607A4 (en) IMPROVED SYNTHESIS
EP2970113A4 (en) NOVEL CONNECTIONS
GB201316764D0 (en) Novel compounds
GB201316762D0 (en) Novel compounds
IL241475A0 (en) method for synthesis
GB201322704D0 (en) Synthesis
SG11201509200QA (en) Synthesis of a substituted furan
GB201322922D0 (en) Synthesis of Polyoxometalates
SG10201701021XA (en) Method of synthesis
GB201310660D0 (en) Synthesis of nucleosides
GB201401185D0 (en) Novel compounds